Compare LEXX & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | DTSS |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 7.4M |
| IPO Year | 2011 | 2026 |
| Metric | LEXX | DTSS |
|---|---|---|
| Price | $2.86 | $0.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 72.9K | ★ 5.8M |
| Earning Date | 11-27-2026 | 10-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $705,923.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6,915.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 52.05 | N/A |
| 52 Week Low | $0.35 | $0.53 |
| 52 Week High | $21.60 | $2.29 |
| Indicator | LEXX | DTSS |
|---|---|---|
| Relative Strength Index (RSI) | 35.35 | 37.05 |
| Support Level | $2.79 | $0.57 |
| Resistance Level | $12.98 | $0.98 |
| Average True Range (ATR) | 0.42 | 0.08 |
| MACD | 0.20 | -0.03 |
| Stochastic Oscillator | 11.57 | 4.77 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Datasea Intelligent Technology Ltd, formerly known as Datasea Inc, is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).